M2 Proton Channel: Difference between revisions

Michal Harel (talk | contribs)
No edit summary
No edit summary
 
(3 intermediate revisions by one other user not shown)
Line 1: Line 1:
<StructureSection load='1nyj' size='340' side='right' caption='The closed state structure of M2 protein H+ channel by solid state NMR spectroscopy ([[1nyj]])' scene=''>
== M2 Proton Channel from ''Influenza'' A Virus ==
== M2 Proton Channel from ''Influenza'' A Virus ==
<applet load='1nyj' size='300' frame='true' align='right' caption='The closed state structure of M2 protein H+ channel by solid state NMR spectroscopy. [Stouffer et al, 2008] [[1nyj]]' />
== Background ==
== Background ==
The M2 proton channel is a key protein that leads to viral infection.<ref name="Takeuchi" /> The M2 proton channel acidifies the virion which allows the viral matrix protein (M1) to disassociate from the ribonucleoprotein (RNP).<ref name="Wu">PMID:12972147 </ref> This allows the RNP to be transported to the nucleus of the cell. Several recent studies have looked at the effects of <scene name='User:Sarah_Henke/Sandbox_1/Amantadine/1'>amantadine</scene> ([[Symmetrel]])<ref name="Stouffer">PMID:18235504 </ref> and <scene name='User:Sarah_Henke/Sandbox_1/Rimantadine/1'>rimantadine</scene> ([[Flumadine]])<ref name="Schnell">PMID:18235503 </ref> on inhibiting the transfer of protons through the M2 channel.<ref name="Stouffer" /> Amantadine is a proton surrogate that competes with protons for binding to His37, the residue involved in the gating mechanism.<ref name="Lear" /><ref>PMID:3662473</ref><ref>PMID:17156962</ref> It has been found that M2 is resistant to these two drugs in 90% of humans, birds and pigs. Understanding the structure and function of this proton channel is necessary in solving the resistance problem.<ref name="Stouffer" />
The M2 proton channel is a key protein that leads to viral infection.<ref name="Takeuchi" /> The M2 proton channel acidifies the virion which allows the viral matrix protein (M1) to disassociate from the ribonucleoprotein (RNP).<ref name="Wu">PMID:12972147 </ref> This allows the RNP to be transported to the nucleus of the cell. Several recent studies have looked at the effects of <scene name='User:Sarah_Henke/Sandbox_1/Amantadine/1'>amantadine</scene> ([[Symmetrel]])<ref name="Stouffer">PMID:18235504 </ref> and <scene name='User:Sarah_Henke/Sandbox_1/Rimantadine/1'>rimantadine</scene> ([[Flumadine]])<ref name="Schnell">PMID:18235503 </ref> on inhibiting the transfer of protons through the M2 channel.<ref name="Stouffer" /> Amantadine is a proton surrogate that competes with protons for binding to His37, the residue involved in the gating mechanism.<ref name="Lear" /><ref>PMID:3662473</ref><ref>PMID:17156962</ref> It has been found that M2 is resistant to these two drugs in 90% of humans, birds and pigs. Understanding the structure and function of this proton channel is necessary in solving the resistance problem.<ref name="Stouffer" />
See [[Rimantadine]] and [[Treatments:Influenza]].


== Animation of Opening and Closing ==
== Animation of Opening and Closing ==
Line 30: Line 28:
*[[Membrane Channels & Pumps]]
*[[Membrane Channels & Pumps]]
<br />
<br />
 
*[[Rimantadine]]<br />
*[[Amantadine]]<br />
*[[Treatments:M2 Proton Channel Inhibitor Pharmacokinetics]]<br />
*[[Treatments:Influenza]].
</StructureSection>
== References ==
== References ==
<references />
<references />

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Sarah Henke, David Canner, Michal Harel, Eric Martz, Alexander Berchansky